MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/froh.2021.676643

Медицинская библиотека · Frontiers in oral health · 2021

Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer.

Bos Tasia, Ratti J Alex, Harada Hisashi

СтатьяОбзорПеревод в очереди

Аннотация

Head and neck cancer is the sixth leading cancer worldwide; head and neck squamous cell carcinoma (HNSCC) accounts for more than 90% of incident cases. In the US, cases of HNSCC associated with human papillomavirus (HPV) have been growing in proportion amongst a younger demographic with superior outcomes to the same treatments, relative to cases associated with tobacco. Yet failures to improve the long-term prognosis of advanced HNSCC over the last three decades persist in part due to intrinsic and acquired mechanisms of resistance. Deregulation of the pathways to respond to stress, such as apoptosis and autophagy, often contributes to drug resistance and tumor progression. Here we review the stress-response pathways in drug response and resistance in HNSCC to explore strategies to overcome these resistance mechanisms. We focus on the mechanisms of resistance to current standard cares, such as chemotherapy (i.e., cisplatin), radiation, and cetuximab. Then, we discuss the strategies to overcome these resistances, including novel combinations and immunotherapy.

Для цитирования: Bos Tasia, Ratti J Alex, Harada Hisashi. Targeting Stress-Response Pathways and Therapeutic Resistance in Head and Neck Cancer.. Frontiers in oral health. 2021. DOI: 10.3389/froh.2021.676643.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.